Aclaris Therapeutics (ACRS) Other Working Capital Changes (2014 - 2025)
Aclaris Therapeutics (ACRS) posted quarterly Other Working Capital Changes of -$854000.0 for Q1 2026, down 2.52% year-over-year from -$876086.2 in Q1 2025, and up 34.61% quarter-over-quarter from -$1.3 million in Q4 2025.
Aclaris Therapeutics (ACRS) Other Working Capital Changes (2014 - 2025) Analysis & Trends
Aclaris Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$854000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 2.52% year-over-year to -$854000.0; the TTM figure through Mar 2026 stood at -$3.8 million (changed N/A YoY), while the FY2025 annual figure was -$3.8 million, down 115.95% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$854000.0, up from -$1.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $8.6 million in Q4 2024, with the low at -$8.2 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $271500.0 (2022), against an average of $391666.7.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes retreated 28.04% in 2025, then decreased 2.52% in 2026.
- Aclaris Therapeutics' Other Working Capital Changes stood at -$1.0 million in 2024, then declined by 28.04% to -$1.3 million in 2025, then soared by 34.61% to -$854000.0 in 2026.
- Business Quant data shows ACRS's Other Working Capital Changes at -$854000.0 in Q1 2026, -$1.3 million in Q4 2025, and -$715000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | -8.21 Mn |
| Mar 31, 2025 | -8.21 Mn |
| Mar 31, 2025 | -8.21 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -273,000.00 |
| Jun 30, 2024 | -273,000.00 |
| Jun 30, 2024 | -273,000.00 |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Dec 31, 2023 | -7.98 Mn |
| Dec 31, 2023 | -7.98 Mn |